Applications of Long Read Sequencing technologies
Date: January 23, 2024
Join Diamond Age's scientific experts and draw on their expertise from working with their clients across biotech and pharma, plus prior employers like the Broad Institute, Dana-Farber and Novartis.
Long Read Sequencing’s ability to provide accurate, contiguous, and in-depth insights into genomes and genetic processes makes it a valuable tool in biotech research and product development.
In this roundtable, we will discuss the ins and outs of Long Read Sequencing and how it helps drug discovery companies through
- Functional Genomics
- Population Genetics
- Drug Development
Request An Invite
Our Roundtable Host
Ph.D in Cellular & Molecular Physiology from Tufts, B.A. Biology from Cornell. Postdoc at Harvard Medical School
Jason brings the insight of a molecular biologist and the technical acumen of an engineer to Diamond Age. In a previous role at Courtagen Life Sciences — where he was one of the first hires — he built the company’s bioinformatics pipeline and operation, including a team of 10, from scratch. He has also held senior roles in both data analysis and technical development at many leading genomics startups, including Applied Biosystems (now Thermo Fisher), RainDance Technologies, Veritas Genetics, and Olaris Therapeutics.
Jason holds a Ph.D. in Cellular and Molecular Physiology from the Tufts University School of Medicine, and a B.A. in Biology from Cornell University. He completed his postdoc at Harvard Medical School.